New Opportunity
|
June 12 (Pre-App)
August 28 (Inv Sub)
|
Sr Faculty |
Federal |
Ovarian |
Congressionally Directed Medical Research Programs (CDMRP)
- Ovarian Cancer Research Program (OCRP) Teal Innovator Award
Supports an individual from any field principally outside of, but not
exclusive of, ovarian cancer, to pursue novel, visionary, high-risk
ideas that could lead to the elimination of ovarian cancer.
Applicants must demonstrate national or international recognition
in their fields.
Due Date:
|
June 12 (Pre-App)
August 28 (Invited Submissions)
|
Amount & Project Period:
|
$500,000/yr direct costs for 5 years
|
|
Eligibility:
|
Professor or equivalent
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-OCRP-TIA
|
|
New Opportunity |
June 12 (Pre App)
Aug 28 (Inv Sub) |
Early Career Investigators |
Federal |
Ovarian Cancer |
CDMRP Ovarian Cancer Academy Award - Early Career Investigator
Supports the addition of early career investigators to a virtual academy that will provide intensive
mentoring, national networking, and a peer group. A designated mentor experienced in ovarian cancer research
with ovarian cancer funding and preliminary data are required.
An institutional match of $50,000 per year is required.
Due Date:
|
June 12 - Pre-applications
August 28 - Invited Submissions
|
Amount & Project Period:
|
$145,000/yr direct costs for 5 years
|
|
Eligibility:
|
Faculty within 3 years of first position (tenure-track or non-tenure
track).
May be research or physician scientists.
Must have 50% institutional supported protected time. |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-OCRP-OCA
|
|
New Opportunity |
June 12 (Pre-App)
Aug 28 (Inv Sub) |
Postdocs/Jr. Faculty |
Federal |
Ovarian Cancer |
CDMRP - Ovarian Cancer Research Program Pilot Award
Support innovative, high-risk/high-reward research. Innovation and impact are important
review criteria. Preliminary data are not required, but are allowed. Clinical
trials are not allowed.
Optional Nested Teal Postdoctoral Scholar: applications from postdocs that meet the criteria outlined
will qualify for a higher level of funding.
Due Date:
|
June 12 (Pre-app)
August 28 (Invited Submissions)
|
Amount & Project Period:
|
$225,000 total direct costs over 2 years
OR
$300,000 with qualified optional nested Teal Postdoctoral Scholar.
|
|
Eligibility:
|
Postdocs or above.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-OCRP-PA
|
|
New Opportunity |
June 14 (LOI)
July 31 (App) |
All Faculty |
Federal |
Disparities |
Closing the Gap in Healthcare Disparities Through
Dissemination and Implementation of Patient Centered Outcomes Research
To identify strategies to engage stakeholders through decision making to implement interventions focused on the reduction
of healthcare disparities in under-resourced settings.
Due Date:
|
June 14 (LOI)
July 31 (App)
|
Amount & Project Period:
|
$500,000/yr (Including Indirects) for 3 years
|
|
Eligibility:
|
All Faculty.
10% effort annually.
Only one PI per proposal.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA-HS-13-010
|
|
New Opportunity |
June 15 (LOI)
Aug 15 (App)
|
All Faculty |
Federal |
PCORI
|
The Patient-Centered Research Institute (PCORI) Cycle 3 Funding
Awards will be made in the following categories:
Assessment of Prevention, Diagnosis, and Treatment Options-- Project addressing
critical decisions patients, caregivers, and clinicians face with too little
information.
Improving Healthcare Systems - Projects addressing critical decisions facing
healthcare systems and the patients and caregivers who rely on them, and
clinicians who work within them.
Communications and Dissemination - Projects addressing critical elements in the
communication and dissemination process among patients, caregivers, and
clinicians.
Addressing Disparities - Studies on overcoming barriers that disproportionately
affect outcomes of specific groups of patients.
Improving Methods for Conducting Patient Centered Outcomes Research - address
gaps in methodological research relevant to conducting PCOR.**
Due Date:
|
June 15
|
Amount & Project Period:
|
$500,000/yr direct costs total for 3 years
**$250,000/yr direct costs for 3 years |
|
Eligibility:
|
All Faculty |
Contact:
|
Linda Nolan, x6071
|
|
New Opportunity |
|
June 16 |
All Faculty |
Federal |
NK Cells |
Enhancing Tumoricidal Activity of Natural
Killer (NK) Cells by Dietary Components for Cancer Prevention
Establish physiological significance of dietary components in modulating the tumoricidal
cell activity of NK cells for cancer prevention.
Due Date:
|
June 16
|
Amount & Project Period:
|
$275,000 total direct costs over 2 years.
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PA-11-161
|
|
|
New Opportunity
|
|
June 16 |
All Faculty |
Federal |
Infection
Associated Cancers |
Biomarkers of Infection-Associated Cancers
To identify biomarkers for cancers where the etiology of the disease is attributed to
infectious agents.
Due Date:
|
June 16
|
Amount & Project Period:
|
$275,000 total direct costs over 2 years.
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PA-11-159
|
|
|
|
June 16 |
All Faculty |
Federal |
Short-term projects |
Small Grants Program for Cancer Research
Supports small, short-term research projects on cancer.
Due Date:
|
June 16
|
Amount & Project Period:
|
$100,000 total direct costs for 1 year
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-144
|
|
New Opportunity |
June 18 (Pre-App)
July 2 (Inv Sub) |
Jr. Faculty |
Federal |
Breast Cancer |
CDMRP Breast Cancer Research Program (BCRP)
Era of Hope Scholar Award
This funding supports
individuals early in their careers and have demonstrated significant potential
for innovation in breast cancer research.
Please note that experience in breast cancer research is not required,
however the application must focus on breast cancer.
Due Date:
|
June 18 - Pre-applications
July 2 - Invited submissions
|
Amount & Project Period:
|
$500,000/yr direct costs over 5 years
|
|
Eligibility:
|
Independent investigators within 6 years of last mentored position.
PI must commit at least 50% effort on breast cancer research during award period.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-BCRP-EOHS
|
BRCP Postdoctoral Fellowship Award
Supports recent doctoral or medical graduates in pursuit of breast cancer research during postdoctoral training
to obtain the experience for an independent career.
Due Date:
|
June 18 - Pre-applications
July 2 - Invited submissions
|
Amount & Project Period:
|
$100,000 direct costs/yr for 3 years |
|
Eligibility:
|
Postdoctoral Fellows with less than 4 years total postdoc research experience and no more than
2 years in current clinical research or laboratory setting conducting the proposed research project.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-BCRP-POSTDOC
|
|
|
|
June 18 |
All Faculty |
Federal |
Tobacco Control |
Tobacco Control Regulatory Research
Research that will inform the development and evaluation of regulations on tobacco
product manufacturing, distribution, and marketing.
Due Date:
|
June 18
|
Amount & Project Period:
|
R01: No funding limit - 5 years.
R21: $275,000 total over 2 years.
R03: $50,000/yr for 2 years.
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Links:
|
R01:
PAR-12-267
| R21:
PAR-12-266
| R03:
PAR-12-268
|
|
|
|
June 18 |
Sr. Faculty |
Federal |
Clinical Onc
Training Program |
Paul Calabresi Career Development Award
for Clinical Oncology
The purpose of the Paul Calabresi Career Development Award for Clinical Oncology is to increase
the number of clinicians and PhD scientists who are trained to design and test clinical therapeutic
research protocols, conduct patient-oriented cancer therapeutic research in team research environments,
and to support the career development of investigators who have made a commitment to focus their
research endeavors on patient-oriented research.
Due Date:
|
June 18
|
Amount & Project Period:
|
$750,000/yr direct costs for 5 years
|
|
Eligibility:
|
Senior Faculty |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-201
|
|
|
June 18
November 18
|
All Faculty |
Federal |
Cancer Biology |
Collaborative Research in Integrative Cancer Biology
To encourage new research into integrative cancer biology by fostering
collaborations between investigators currently supported through the
Integrative Cancer Biology Program (ICBP) and those currently unaffiliated
with the ICBP.
Due Date:
|
June 18
November 18
|
Amount & Project Period:
|
No funding limit - 5 years
|
|
Eligibility:
|
Collaborating teams must be comprised of at
least one ICBP investigator and at least one non-ICBP-affiliated
investigator.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-184
|
|
New Opportunity |
June 19 (Pre-app)
Oct 9 (Inv Sub) |
All Faculty |
Federal |
Prostate Cancer |
CDMRP Prostate Cancer Research Programs (PCRP):
Transformative Impact Award Grant
To achieve near-term clinical impact for patients, the scope of research effort is expected to include
translational research, clinical research, and/or clinical trials and address one of the PCRP focus areas and overarching
challenges. The Transformative Impact Award mechanism encourages multi-institutional applications with up to 3 PIs, each
of whom will receive a separate award.
Due Date:
|
June 19 - Pre-application
October 9 - Invited submission
|
Amount & Project Period:
|
$5,000,000 total direct costs over 3 years
|
|
Eligibility:
|
PI(s) must be at or above Assistant Professor or equivalent.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-PCRP-TIA
|
Laboratory-Clinical Transition Award
Supports product-driven preclinical studies of lead agents or medical devices that have
potential to effect prostate cancer clinical care.
Due Date:
|
June 19 - Pre-application
October 9 - Invited submissions
|
Amount & Project Period:
|
$500,000/yr direct costs for 3 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81CWH-13-PCRP-LCTA
|
Biomarker Development Award
Support for research aimed at multi-institutional validation of prostate cancer
biomarkers for crucial decision-making in prostate cancer management.
Due Date:
|
June 19 - Pre-application
October 9 - Invited submissions
|
Amount & Project Period:
|
$750,000/yr direct costs over 3 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-PCRP-BDA
|
Synergistic Idea Development Award
The award supports innovative approaches to prostate cancer research involving
two or three independent Principal Investigators (PIs). Investigators should use synergistic perspectives
to address a central problem or question in prostate cancer research. This award is designed to support both new and pre-existing partnerships.
Due Date:
|
June 19 - Pre-application
October 9 - Invited submissions
|
Amount & Project Period:
|
$250,000/yr direct costs for 3 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-PCRP-SIDA
|
Idea Development
Supports innovative approaches to prostate cancer research.
Due Date:
|
June 19 - Pre-application
|
Amount & Project Period:
|
$125,000/yr direct costs for 3 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-PCRP-IDA
|
|
|
June 19 (LOI)
Sept 27 (App) |
All Faculty |
Federal |
CDRNs |
The National Patient-Centered Clinical Research Network:
Clinical Data Research Networks (CDRN) - Phase One
Clinical Data Research Networks (CDRNs) that will develop the capacity
to conduct randomized comparative effectiveness studies using data
from clinical practice in a large, defined population.
Due Date:
|
June 19 (LOI)
September 27 (App)
|
Amount & Project Period:
|
$7,000,000 total (including indirects) over 18 months
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
CDRN - Phase One
|
|
|
June 19
November 19 |
All Faculty |
Federal |
Drug Delivery |
Image-guided Drug Delivery in Cancer
Supports innovative projects focused on image-guided drug delivery (IGDD), including
real-time image guidance, monitoring, quantitative in vivo characterizations and validation
of delivery and response.
Due Date:
|
June 19
November 19
|
Amount & Project Period:
|
No funding limit - 5 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-185
|
|
New Opportunity |
June 20 (Pre-app)
Oct 16 (Inv Sub) |
All Faculty/New Investigator Option |
Federal |
Lung Cancer |
CDMRP Lung Cancer Research Program
Idea Development Award
Support new ideas that are in early stages of development This mechanism offers
a New Investigator Option for independent investigators in the early stages of
their careers within 10 years of their first appointment. This option is
designed to allow early career investigators separately from established
investigators.
Due Date:
|
June 20 - Pre Application
October 16 - Invited Submissions
|
Amount & Project Period:
|
$120,000/yr direct costs for 2 years.
|
|
Eligibility:
|
Instructor or Assistant Professor within 5 years of first faculty appointment.
Demonstrated institutional commitment of at least 50% protected time for the proposed research.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-LCRP-IDA
|
Career Development Award
Support early career investigators conducting research under the mentorship of an
experienced lung cancer researcher.
Due Date:
|
June 20 - Pre-applications
October 16 - Invited submissions
|
Amount & Project Period:
|
$120,000/yr direct costs for 2 years.
|
|
Eligibility:
|
Junior Faculty within 5 years of
first appointment.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-LCRP-CDA
|
|
|
|
June 20
November 20 |
All Faculty |
Federal |
Health
Disparities |
Basic Cancer Research in Cancer Health Disparities
Encourage applications from investigators interested in conducting basic, mechanistic
research into the biologic/genetic causes of cancer health disparities.
Due Date:
|
June 20
November 20
|
Amount & Project Period:
|
$250,000/yr for 5 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-095
|
|
New Opportunity |
June 21 (Pre-App)
Sept 11 (Inv Sub) |
All Faculty |
Federal |
Ovarian Cancer |
CDMRP - Ovarian Cancer Research Program (OCRP)
Clinical Translational Leverage Award
Leverage existing human-based ovarian cancer resources in translational research
to address unmet needs in ovarian cancer, particularly adjunct analyses associated with clinical trials.
Due Date:
|
June 21 - Pre-application
September 11 - Invited submission
|
Amount & Project Period:
|
$125,000/yr direct costs for 2 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-OCRP-TLA
|
Resource Development Award
Support for product-driven research aimed at developing tools to facilitate research in ovarian cancer.
Due Date:
|
June 21 - Pre-application
September 11 - Invited submission
|
Amount & Project Period:
|
$80,000/yr direct costs for 5 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-OCRP-RDA
|
|
New Opportunity |
June 25 (Pre-app)
Sept 25 (Inv Sub) |
All Faculty |
Federal |
Breast |
CDMRP Breast Cancer Research Program
Breast Cancer Breakthrough Award
Four levels are available:
Due Date:
|
June 25 - Pre-application
|
Eligibility:
|
All Faculty
|
|
Contact
|
Linda Nolan, x6071
|
|
Level I
|
Innovative high risk/high reward research in
earliest stages of idea development.
- $350,000 total direct costs over 3 years |
|
Level II
|
Research supported by preliminary data with
potential to advance translation from the lab to the clinic.
-
$700,000 total direct costs over 3 years
|
|
Level III:
|
Advanced translational studies with potential for
near-term clinical investigation. Small clinical trials may apply.
- $250,000/yr direct costs for 5 years
|
|
Level IV
|
Large-scale projects that will transform clinical management of breast
cancer.
- $2 million/yrdirect costs for 5 years.
|
RFA Link:
|
W81XWH-13-BCRP BREAKTHROUGH
|
Innovator Award
Provide support for novel ideas that could lead to ending breast cancer.
Due Date:
|
June 25 - Pre-application
September 25 - Invited submissions
|
Amount & Project Period:
|
$1 million/yr total direct costs for 5 years.
|
|
Eligibility:
|
PI must be at or above Associate Professor or
equivalent. |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-BCRP-INNOV
|
|
New Opportunity |
June 26 (Pre-App)
Sept 17 (Inv Sub) |
All Faculty |
Federal |
Bone Marrow
Failure |
CDMRP-Bone Marrow Failure Research Program Idea Development Award
Supports innovative ideas and high impact approaches to bone marrow
failure research. Proposals may include relevant preliminary data, but
clinical trials will not be supported.
Due Date:
|
June 26 (Pre-application)
September 17 (Invited Submissions)
|
Amount & Project Period:
|
$120,000/yr direct costs for 3 years |
|
Eligibility:
|
All Faculty |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-BMFRP-IDA
|
|
New Opportunity |
|
June 28 |
Medical Doctors |
Non-Federal |
Drug Repurposing |
Reliable Cancer Therapies (RCT) Cancer Projects
Support projects to repurpose existing drugs for cancer treatment. The drugs must have been developed and
approved for other indication(s). Relevant clinical trial endpoints (cancer survival & tumor response)
should be the primary research assessments.
Due Date:
|
June 28 (8:00am GMT)
|
Amount & Project Period:
|
€100,000/yr for 3 years
|
|
Eligibility:
|
PI or co-PI must have Medical Degree
|
Contact:
|
Shaina Sine, x3658
|
RFA Link:
|
RCT Cancer Projects
|
|
New Opportunity |
June 28 (Pre-App)
August 15 (Invited Sub) |
All Faculty |
Federal |
Payment/Delivery
Services |
The Centers for Medicare & Medicaid Services (CMS) Health Care Innovation
Awards Round Two
Support proposals that test new payment and service delivery models that will deliver
better care and lower costs for Medicare, Medicaid, and Children's Health Insurance
Program (CHIP) enrollees.
Due Date:
|
June 28 (Pre-app)
August 15 (Invited submissions)
|
Amount & Project Period:
|
No amount given - 3 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
CMS-1C1-14-001
|
|
|
|
July 1 |
Postdocs |
Non-Federal |
Career Development |
The Helen Hay Whitney Foundation - Research Fellowships
Supports early postdoctoral research training in basic biomedical sciences.
Due Date:
|
July 1
|
Amount & Project Period:
|
Stipend:
$49,000 total year 1
$50,000 total year 2
$51,000 total year 3
Allowance:
$1,500/yr for 3 years
|
|
Eligibility:
|
Postdoctoral fellows with less than 1 year training and US citizen.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
The Helen Hay Whitney Foundation Research Fellowship
|
|
New Opportunity |
July 9 (Pre-app)
Oct 16 (Inv Sub) |
All Faculty |
Federal |
Lung Cancer |
CCDMRP Lung Cancer Research Program (LCRP)
Clinical Exploration Award
Support early-phase clinical trials investigating interventions that could
have an impact on the clinical management of lung cancer.
Due Date:
|
July 9 - Pre-application
October 16 - Invited submissions
|
Amount & Project Period:
|
$150,000/yr direct costs for 3 years.
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-LCRP-CEA
|
|
|
|
July 15 (LOI)
Aug 15 (App) |
All Faculty |
Federal |
Oral Cancer |
Functional Characterization of Oral Cancer Initiating
Cells
Support translational projects in oral cancer aimed at understanding the cellular, molecular and
functional properties of oral Cancer Initiating Cells (CICs)and their niches.
Due Date:
|
July 15 (LOI)
August 15 (App)
|
Amount & Project Period:
|
R01: No funding limit - 4 years.
R21: $275,000 total over 2 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Links:
|
R01:
RFA-DE-14-001
|
R21: RFA-DE-14-002
|
|
New Opportunity |
July 16 (Pre-app)
Oct 22 (Inv sub) |
All Faculty |
Federal |
Multiple Cancer Areas |
CDMRP - Peer Reviewed Cancer Research Program (PRCRP)
Idea Award with Special Focus
Support research projects in any one of 10 special topic areas - blood cancers, colorectal cancer, genetic cancer research, kidney cancer, listeria vaccine for cancer,
melanoma and other skin cancers, mesothelioma, neuroblastoma, pancreatic cancer and pediatric brain tumors.
Due Date:
|
July 16 - Pre-application
October 22 - Invited Submissions
|
Amount & Project Period:
|
$150,000/yr direct costs for 2 years
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-PRCRP-IA
|
|
New Opportunity |
July 16 (Pre-app)
October 22 (Inv Sub) |
Jr Faculty |
Federal |
Multiple Areas |
Career Development Award
Supports young investigators with the mentorship of an experienced cancer researcher
in at least one of these 10 special topic areas - blood cancers, colorectal cancer, genetic cancer research, kidney cancer, listeria vaccine for cancer,
melanoma and other skin cancers, mesothelioma, neuroblastoma, pancreatic cancer and pediatric brain tumors.
May include Optional Nested Postdoctoral Fellow Traineeship.*
Due Date:
|
July 16 - Pre-application
October 22 - Invited submissions
|
Amount & Project Period:
|
$120,000/yr direct costs for 2 years
$180,000/yr direct costs for 2 years (Nested
Postdoctoral Fellow Traineeship Option)
|
|
Eligibility:
|
Junior Faculty (within 7 years of first faculty
appointment) |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
W81XWH-13-PRCP-CDA
|
*Optional Nested Postdoctoral Fellow Traineeship: provides primarily salary support for training a motivated
postdoctoral fellow interested in pursuing a career in cancer research. The designated mentor of the trainee must
be the PI of the Career Development Award application.
|
New Opportunity |
July 17 (Pre-app)
July 31 (Inv Sub) |
All Faculty |
Federal |
Lung Cancer |
CDMRP Lung Cancer Research Program (LCRP)
Concept Award
Support highly innovative concepts in lung cancer research.
Due Date:
|
July 17 - Pre-application
July 31 - Invited submissions
|
Amount & Project Period:
|
$100,000 total direct costs for 1 year
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
CDMRP Lung Cancer Research Program
Program announcement will be available in June
|
|
|
|
August 1 |
All Faculty |
Internal |
Infection Cancer |
Center for Infection Research In Cancer (CIRC) Funding Opportunity
An intramural grant program to fund pilot projects that will bring together multidisciplinary strengths of Moffitt to meet
the goals of the CIRC.
Due Date:
|
August 1 at 4:00pm
|
Amount & Project Period:
|
$50,000 for 12 months
|
|
Eligibility:
|
All Faculty
|
Contact:
|
Maureen Ahearn, x8824
|
RFA Link:
|
CIRC Website
|
|
|
|
August 2 |
All Faculty |
Non-Federal |
Mesothelioma |
The Meso Foundation Grants for Mesothelioma Research
Fund projects in mesothelioma research in basic, translational or clinical areas that are
not presently funded or pending review.
|
New Opportunity |
|
August 21 |
Jr Faculty |
Non-Federal |
Public Health |
Public Health Services and Systems Research (PHSSR):
Mentored Research Scientist Development Awards
To strengthen the pool of researchers available to conduct PHSSR and to build on successful
principles and models previously demonstrated in public health and health services research.
Due Date:
|
August 21
|
Amount & Project Period:
|
$50,000/yr total for 2 years
|
|
Eligibility:
|
Jr. Faculty (within 7 years of doctorate degree)with a
research or professional doctoral degree in public health or related discipline
with a demonstrated career commitment to PHSSR.
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PHSSR Mentored Research Scientist Development Award
|
|
New Opportunity |
|
August 30 |
Sr Faculty |
Non-Federal |
Gastric Cancer |
AGA R. Robert and Sally Funderburg Research Award
in Gastric Cancer
This funding supports novel approaches in gastric cancer research.
Due Date:
|
August 30
|
Amount & Project Period:
|
$50,000/yr total for 2 years
|
|
Eligibility:
|
Sr Investigators established in the field of
gastric biology and a member of AGA at the time of submission. |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
Funderburg Research Award in Gastric Cancer
|
|
|
|
October 14 (LOI)
November 14 (App) |
All Faculty |
Federal |
Microbial Metabolites |
The Role of Microbial Metabolites in Cancer
Prevention and Etiology
Stimulate preclinical and clinical research to describe the effect of microbially
generated metabolites in cancer prevention/progression
Due Date:
|
October 14 (LOI)
November 14 (App)
|
Amount & Project Period:
|
No funding limit - 5 years
|
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-159
|
|
|
|
|
October 18 |
Junior Faculty |
Non-Federal |
Gastric Cancer |
American Gastroenterological Association Foundation
Research Scholar Awards
Supports the development of independent research careers in digestive diseases, including gastric cancer.
Due Date:
|
October 18
|
Amount & Project Period:
|
$90,000/yr total for 2 years
|
|
Eligibility:
|
Junior Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
AGA RSA
|
|
|
|
|
| Toolbox |
|
|
| |
|
|
Questions?
MRISignals@moffitt.org
|
 |
